Patents by Inventor Omar L. Sprockel

Omar L. Sprockel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6627224
    Abstract: Compositions containing a low dose of entecavir are administered on a daily basis to treat hepatitis B virus infection and/or co-infections. Formulations for the oral administration of a low dose of entecavir are provided. Other pharmaceutically active substances can be included in the entecavir composition or can be separately administered for the treatment of hepatitis B virus infection or for the treatment of co-infected patients.
    Type: Grant
    Filed: February 23, 2001
    Date of Patent: September 30, 2003
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Richard J. Colonno, Omar L. Sprockel, Abizer Harianawala, Divyakant Desai, Michael G. Fakes
  • Patent number: 6342247
    Abstract: Pharmaceutical compositions containing irbesartan, alone or in combination with a diuretic, providing tablets with a high relative amount of active agent and excellent wetting and disintegration properties.
    Type: Grant
    Filed: October 11, 2000
    Date of Patent: January 29, 2002
    Assignee: Sanofi-Synthelabo
    Inventors: Cathy C. Ku, Omar L. Sprockel, Beth A. Lang, Divvakant S. Desai
  • Publication number: 20010033864
    Abstract: Compositions containing a low dose of entecavir are administered on a daily basis to treat hepatitis B virus infection and/or co-infections. Formulations for the oral administration of a low dose of entecavir are provided. Other pharmaceutically active substances can be included in the entecavir composition or can be separately administered for the treatment of hepatitis B virus infection or for the treatment of co-infected patients.
    Type: Application
    Filed: February 23, 2001
    Publication date: October 25, 2001
    Inventors: Richard J. Colonno, Omar L. Sprockel, Abizer Harianawala, Divyakant Desai, Michael G. Fakes
  • Patent number: 5994348
    Abstract: Pharmaceutical compositions containing irbesartan, alone or in combination with a diuretic, providing tablets with a high relative amount of active agent and excellent wetting and disintegration properties.
    Type: Grant
    Filed: May 20, 1998
    Date of Patent: November 30, 1999
    Assignee: Sanofi
    Inventors: Cathy C. Ku, Omar L. Sprockel, Beth A. Lang, Divyakant S. Desai